BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 50.16% | -37.33% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.59% | -59.03% | |||
| Operating Income | -22.59% | 59.03% | |||
| Income Before Tax | -25.13% | 60.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.13% | 60.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.13% | 60.80% | |||
| EBIT | -22.59% | 59.03% | |||
| EBITDA | -23.02% | 59.49% | |||
| EPS Basic | -24.61% | 66.91% | |||
| Normalized Basic EPS | -24.60% | 66.70% | |||
| EPS Diluted | -24.61% | 67.25% | |||
| Normalized Diluted EPS | -24.60% | 66.70% | |||
| Average Basic Shares Outstanding | 0.42% | 17.75% | |||
| Average Diluted Shares Outstanding | 0.42% | 17.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||